Cinque abitudini per mangiare sano e rispettare ritmo circadiano
Search Results for: Un esame del sangue predice il rischio di ammmalarsi di Alzheimer
Here's what we've found for you
Linee guida sulla degenerazione maculare legata all’età
La forma neovascolare della degenerazione maculare legata all’età (AMD) è […]
'Per il Papa un mese di allerta e no ai viaggi'
Pneumologo: ‘Segnali positivi, ma c’è il rischio di recidiva’
Dalla cottura all'igiene, ecco come proteggersi dalla Listeria
Alcune semplici regole riducono il rischio di contrarre la listeriosi
Blood Biomarkers to Detect Alzheimer Disease
To the Editor In their excellent research, Dr Palmqvist and colleagues report high diagnostic accuracy of blood biomarkers in the diagnosis of Alzheimer disease. The authors used the STROBE checklist for observational studies, but this is a prospective diagnostic accuracy study, for which the STARD checklist is more appropriate.
Blood Biomarkers to Detect Alzheimer Disease—Reply
In Reply We appreciate the opportunity to respond to Dr Mintzker’s thoughtful comments regarding our study on the diagnostic accuracy of blood biomarkers for the detection of Alzheimer disease.
Schillaci, finanziato con 35 milioni Fondo per l'Alzheimer
‘Ministero continuerà a sostenere la ricerca in questo settore’
Diabete di tipo 2, una dieta ricca di grassi altera la barriera intestinale
Uno studio dell’Università di Padova e del Vimm ha scoperto […]
Resilience-promoting social networks among unpaid dementia caregivers: protocol for a mixed-methods, 2-year exploratory study
Introduction
Unpaid caregivers of people living with dementia often experience lower levels of perceived life satisfaction and higher rates of depression and anxiety compared with those caring for individuals without Alzheimer’s disease or related dementias. While research on unpaid caregiver well-being and satisfaction has primarily focused on the characteristics of people living with dementia and their dyadic relationships, it has not adequately explored the role of social networks in supporting unpaid caregiver well-being. In this study, we aim to fill this gap by taking an egocentric social network approach to understand the multiple dimensions of social relations among unpaid caregivers of people living with Alzheimer’s disease or related dementia.
Methods and analysis
We will conduct a mixed-method, 2-year exploratory study that involves a structured survey-based telephone interview in year 1 and semistructured interviews in year 2 with caregivers of PLWD recruited through community and healthcare partners. Participants will participate in 1 60-min interview in year 1 (n=100) and a 45–60 min semistructured interview in year 2 (n=75). Eligibility for caregivers includes being an unpaid caregiver, aged 40 years or older, residing and providing care in Arizona or Nevada. The survey consists of questions about caregiver and care recipient demographics, caregiver background, caregiver stress, resilience, well-being and egocentric social network data. Network composition attributes, such as tie strength, the function of the relationship and reliance on network members, will also be assessed. In year 2, qualitative semistructured interviews will supplement these quantitative measures to understand network selection, perceived network changes over time and network strength.
Ethics and dissemination
The Arizona State Institutional Review Board (00018191) approved this study. All participants will receive electronic informed consent documents to review and sign. During the initial interview, participants will be asked if they have any questions about the informed consent documents. We will confirm that participants have completed the required consent form before the start of any research activity. The findings of this study will be disseminated through peer-reviewed journal articles, academic and community presentations, and community-focused publications targeting caregivers.
Regional variations in healthcare in people living with dementia in Germany: protocol for a mixed-methods study
Introduction
Care for people living with dementia is both important and complex, and there is evidence of large regional variations in the quality of care. This study protocol describes design, methods and objectives of an investigation of regional variations in the utilisation, the quality and the costs of care for people living with dementia in Germany.
Methods and analysis
An exploratory, naturalistic, mixed-methods study is being conducted with three modules: Module A: A quantitative analysis of claims data of statutory health insurance will be conducted to investigate regional variations in the utilisation and costs of care. Module B: In selected regions of interest that deviate significantly from the average in terms of utilisation in Module A, the quality of care and patient characteristics, variations and possible causes of these variations in care will be examined in more detail using quantitative and qualitative assessments. Module C: The claims and primary data from modules A and B will be combined, synthesised and evaluated to elicit recommendations for regional healthcare using a participatory consensus method.
Ethics and dissemination
The study is overseen by the German Alzheimer’s Association. The study’s ethics and data protection plan was approved by the data and ethics committee of the leading university, Brandenburg Medical School Theodor Fontane (reference number: 152092023-BO-E) as well as the data committee of the three participating health insurances. Dissemination plans include dissemination of our main results to the general public, people affected, the scientific community and funding-, policy- and decision makers. Study outcomes and conclusions will be published on our own and the funder’s websites, through presentations at conferences and in scientific journals. The funder ensures dissemination of main study results and recommendations for action to relevant organisations and institutions. Publication of the study’s main results is planned within 6 months of the study’s conclusion.
Trial registration number
DRKS00031944 (https://trialsearch.who.int/Trial2.aspx?TrialID=DRKS00031944).
Paracetamolo in gravidanza può aumentare il rischio di iperattività nel bebè
Studio prende in esame un campione di oltre 300 donne
Tumore del pancreas, sperimentato un test del sangue per la diagnosi precoce
Cruciale per questa neoplasia gravata dalla diagnosi tardiva
Un esame del sangue identifica il cancro al pancreas
Gli scienziati dell’Oregon Health & Science University hanno sviluppato PAC-MANN, un […]
Mangiare yogurt può ridurre il rischio di specifici tumori del colon-retto
Uno studio del Mass General Brigham ha scoperto che il […]
Rischio fai da te per emicrania, ruolo chiave delle farmacie
Esperto, il 40% di chi chiede consiglio soffre di emicrania
Mpox, ministero aggiorna le indicazioni su strategia vaccinale
Vaccino offerto a chi è a rischio per comportamenti o condizioni